Information  X 
Enter a valid email address

Oxford Biomedica PLC Ord 1P (OXB)

Related News

04-Sep-2019 07:39 AM

Oxford Biomedica losses deepen as sales fall, R&D costs rise

Gene and cell therapy company Oxford Biomedica booked a deeper first-half loss, after sales fell and it upped spending on R&D. Pre-tax losses for the six months through June amounted to £12.1m, compared to a profit of £5.2m on-year. Revenues
28-May-2019 08:00 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 1060p (from 1010p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Mar-2019 08:10 AM

Broker Forecast - Jefferies International issues a broker note on Oxford BioMedica PLC

Jefferies International today reaffirms its hold investment rating on Oxford BioMedica PLC (LON:OXB) and cut its price target to 725p (from 800p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
04-Jan-2019 08:10 AM

Broker Forecast - Jefferies International issues a broker note on Oxford BioMedica PLC

Jefferies International today reaffirms its hold investment rating on Oxford BioMedica PLC (LON:OXB) and cut its price target to 800p (from 1100p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
13-Sep-2018 08:27 AM

Oxford BioMedica sees 118% jump in gross income, expands bioprocessing capacity

Gene and cell therapy group Oxford BioMedica reported an operating profit of £9.4m for the first half of 2018, compared with a £2.2m loss a year earlier, while gross income jumped 118% to £36m, driven by £20.6 million worth of lice
13-Jun-2018 08:40 AM

Broker Forecast - Jefferies International issues a broker note on Oxford BioMedica PLC

Jefferies International today downgrades its investment rating on Oxford BioMedica PLC (LON:OXB) to hold (from buy) and raised its price target to 1100p (from 825p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmaga
06-Jun-2018 08:40 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 1010p (from 780p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
02-May-2018 12:40 PM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and set its price target at 16p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
09-Apr-2018 09:50 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and set its price target at 16p. Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Mar-2018 09:20 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today reaffirms its buy investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 16p (from 13p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk...
15-Mar-2018 08:38 AM

Oxford BioMedica cuts EBITDA loss

Oxford BioMedica, a gene and cell therapy group, increased its gross income by 28% to £39.4 million in the year to 31 December 2017. Operating expenses excluding depreciation and amortisation and share based payments decreased by 12% to £22.9
15-Feb-2018 08:41 AM

Oxford BioMedica signs agreement with Bioverativ

Oxford BioMedica, a gene and cell therapy group, has signed a major collaboration and licence agreement with Bioverativ for the development and manufacturing of lentiviral vectors to treat haemophilia. The agreement includes a licence to use OXB's
19-Sep-2017 08:40 AM

Broker Forecast - Peel Hunt issues a broker note on Oxford BioMedica PLC

Peel Hunt today initiates coverage of Oxford BioMedica PLC (LON:OXB) with a buy investment rating and price target of 13p. Story provided by StockMarketWire.com...
31-Aug-2017 01:00 PM

Broker Forecast - N+1 Singer issues a broker note on Oxford BioMedica PLC

N+1 Singer today reaffirms its hold investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 10.20p (from 8.70p). Story provided by StockMarketWire.com...
17-Aug-2017 07:43 AM

Oxford BioMedica cuts operating loss

Oxford BioMedica made an operating loss of £2.2 million in the first half of 2017, compared with a loss of £6.9 million the year before. Revenue increased by 26% to £15.7 million. Cash outflow before financing activities reduced to &po
11-Aug-2017 09:08 AM

Oxford BioMedica to lead £2m gene therapy collaboration project

Oxford BioMedica has agreed, as lead partner, to enter into a collaboration agreement with a consortium of partners for a two-year £2 million project focused on gene and cell therapy manufacturing, co-funded by Innovate UK. The aim of the collabora
07-Aug-2017 08:20 AM

Oxford BioMedica wins MHRA commercial supply licence

Oxford BioMedica (OXB) has been granted a licence by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture and distribute lentiviral vector material for commercial supply. This is in addition to the existing licence for Invest
27-Jul-2017 03:20 PM

Broker Forecast - N+1 Singer issues a broker note on Oxford BioMedica PLC

N+1 Singer today reaffirms its hold investment rating on Oxford BioMedica PLC (LON:OXB) and raised its price target to 8.70p (from 7.80p). Story provided by StockMarketWire.com...
30-Jun-2017 03:02 PM

Oxford BioMedica agrees new $55m debt facility

Oxford BioMedica has confirmed that the Company completed a new $55m debt facility with Oaktree Capital Management - Strategic Credit Strategy. The facility has been used to redeem the existing debt facility with Oberland Capital Healthcare. The loan is
23-May-2017 02:10 PM

All resolutions passed at AGM of Oxford BioMedica

Oxford BioMedica has announced that all resolutions proposed were duly passed at its Annual General Meeting, held today in London. At 2:10pm: (LON:OXB) Oxford BioMedica PLC share price was +0.11p at 4.99p Story provided by StockMarketWire.com...
14-Oct-2016 04:10 PM

Broker Forecast - N+1 Singer issues a broker note on Oxford BioMedica PLC

N+1 Singer today upgrades its investment rating on Oxford BioMedica PLC (LON:OXB) to hold (from sell) and set its price target at 330p. Story provided by StockMarketWire.com...
07-Jun-2016 01:25 PM

Oxford BioMedica resolutions passed at AGM

Oxford BioMedica, a leading gene and cell therapy group, has confirmed that all resolutions proposed at its annual general meeting today were passed. At 1:25pm: (LON:OXB) Oxford BioMedica PLC share price was -0.04p at 5.44p Story provided by StockMar
23-Feb-2016 07:25 AM

OXB's GBP8.1m hike

Oxford BioMedica intends to raise GBP8.1m via to a placing of 128.38m new shares at a discounted 6.3p each with both new and existing investors together with the Directors. "The principal purpose of the Placing is to provide adequate working capital
27-Aug-2015 09:56 AM

Higher half year net losses at Oxford Biomedica

Oxford BioMedica (LSE: OXB), ("OXB" or "the Group") a leading gene and cell therapy group, has announced that for the six months ended 30 June 2015 revenue was £4.4m (H1 2014: £4.7 million) due in large part to the Novartis contract.
07-May-2015 01:05 PM

Oxford BioMedica resolutions passed at AGM

Oxford BioMedica has confirmed that all resolutions proposed at its annual general meeting today were passed. At 1:05pm: (LON:OXB) Oxford BioMedica PLC share price was 0p at 11.5p Story provided by StockMarketWire.com...
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t